A Controlled Trial Comparing Ciprofloxacin With Mesalazine for The Treatment of Active Crohn's Disease

1999234 citationsJournal Article

Authors

This study suggests that ciprofloxacin 1 g/day is as effective as mesalazine 4 g/day in treating mild to moderate flare-up of Crohn's disease.

Good health and well-being

Published in: The American Journal of Gastroenterology

Volume 94, Issue 3, pp. 674-678

Field-Weighted Citation Impact: 7.18